Apheresis Technology for Prevention and Regression of Atherosclerosis: An Overview
- 1 August 1997
- journal article
- Published by Wiley in Therapeutic Apheresis
- Vol. 1 (3) , 233-241
- https://doi.org/10.1111/j.1744-9987.1997.tb00144.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Plasmapheresis for Prevention and Regression of Coronary AtherosclerosisAnnals of the New York Academy of Sciences, 2006
- Development of Immunosorbents for apoB-Containing Lipoproteins ApheresisArtificial Organs, 1995
- Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresisThe American Journal of Cardiology, 1994
- Beneficial Effect of Cholesterol-Lowering Therapy on Endothelium-Dependent Coronary Vasodilation in Patients with HypercholesterolemiaaAnnals of the New York Academy of Sciences, 1994
- LDL-apheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitorsThe Lancet, 1993
- Regression of carotid plaques during low density lipoprotein cholesterol elimination.Stroke, 1991
- Improvement of Peripheral Circulation by Low Density Lipoprotein AdsorptionAnnual Northeast Bioengineering Conference, 1989
- LDL-apheresis. Potential procedure for prevention and regression of atheromatous vascular lesion.Japanese Circulation Journal, 1987
- Regression of valvular aortic stenosis due to homozygous familial hypercholesterolemia following plasmapheresisJournal of Molecular Medicine, 1986
- Failure of Complete Bile Diversion and Oral Bile Acid Therapy in the Treatment of Homozygous Familial HypercholesterolemiaNew England Journal of Medicine, 1977